Literature DB >> 19900257

Argentine valuation of the EQ-5D health states.

Federico Ariel Augustovski1, Vilma Edit Irazola, Alberto Pascual Velazquez, Luz Gibbons, Benjamin M Craig.   

Abstract

OBJECTIVE: To develop a set of health state values based on EuroQol EQ-5D instrument for the Argentine general population.
METHODS: Consecutive subjects attending six primary care centers in Argentina were selected based on quota sampling and were interviewed using the EuroQol Group protocol for measurement and valuation of health studies. Initially, the respondents were randomly assigned a unique card set; however, to improve efficiency, the subjects were later randomly assigned to one of three fixed sets of EQ-5D states. Using the visual analog scale (VAS) and time-trade off (TTO) responses for these states, we estimated a valuation model using ordinary least squares regression clustered by respondent. Predicted values for EQ-5D health states are compared with published values for the United States.
RESULTS: Six hundred eleven subjects were interviewed by 14 trained interviewers, rendering 6887 TTO and 6892 VAS responses. The model had an R(2) of 0.897 and 0.928 for TTO and VAS, respectively. The mean absolute difference between observed and predicted values was 0.039 for TTO and 0.020 for VAS, each showing a Lin's concordance coefficient more than 0.98. Argentine and US TTO-predicted values were highly correlated (Pearson's rho = 0.963), although the average absolute difference was clinically meaningful (0.06), rejecting the US values for nearly two-thirds of the states (62.8%). The Argentine population placed lower values on mild states and higher values on severe states.
CONCLUSION: This study provides an Argentine value set that could be used locally or regionally, with meaningful and significant differences with that of the United States. Health policy in Latin America must incorporate local values for sovereignty and validity.

Entities:  

Mesh:

Year:  2008        PMID: 19900257      PMCID: PMC3819816          DOI: 10.1111/j.1524-4733.2008.00468.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  11 in total

1.  Inconsistent responses in three preference-elicitation methods for health states.

Authors:  X Badia; M Roset; M Herdman
Journal:  Soc Sci Med       Date:  1999-10       Impact factor: 4.634

2.  The use of economic evaluation in health care: Australian decision makers' perceptions.

Authors:  J Ross
Journal:  Health Policy       Date:  1995-02       Impact factor: 2.980

Review 3.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

4.  US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

Authors:  James W Shaw; Jeffrey A Johnson; Stephen Joel Coons
Journal:  Med Care       Date:  2005-03       Impact factor: 2.983

5.  Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation.

Authors:  Cynthia P Iglesias; Michael F Drummond; Joan Rovira
Journal:  Int J Technol Assess Health Care       Date:  2005       Impact factor: 2.188

6.  Current trends in the use of pharmacoeconomics and outcomes research in europe.

Authors:  M Drummond; D Dubois; L Garattini; B Horisberger; B Jönsson; I S Kristiansen; C Le Pen; C G Pinto; P B Poulsen; J Rovira; F Rutten; M G von der Schulenburg; H Sintonen
Journal:  Value Health       Date:  1999 Sep-Oct       Impact factor: 5.725

7.  Clinical research and drug development in Latin America: weighing the pros and cons, talking about the future.

Authors:  D G Rodrigues
Journal:  J Investig Med       Date:  2007-07       Impact factor: 2.895

8.  Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans.

Authors:  Victor Zarate; Paul Kind; Ling-Hsiang Chuang
Journal:  Value Health       Date:  2008-05-16       Impact factor: 5.725

9.  Variations in population health status: results from a United Kingdom national questionnaire survey.

Authors:  P Kind; P Dolan; C Gudex; A Williams
Journal:  BMJ       Date:  1998-03-07

10.  Modeling valuations for EuroQol health states.

Authors:  P Dolan
Journal:  Med Care       Date:  1997-11       Impact factor: 2.983

View more
  27 in total

1.  Time trade-off and attitudes toward euthanasia: implications of using 'death' as an anchor in health state valuation.

Authors:  Liv A Augestad; Kim Rand-Hendriksen; Knut Stavem; Ivar Sønbø Kristiansen
Journal:  Qual Life Res       Date:  2012-06-08       Impact factor: 4.147

2.  An EQ-5D-5L value set based on Uruguayan population preferences.

Authors:  Federico Augustovski; Lucila Rey-Ares; Vilma Irazola; Osvaldo Ulises Garay; Oscar Gianneo; Graciela Fernández; Marcelo Morales; Luz Gibbons; Juan Manuel Ramos-Goñi
Journal:  Qual Life Res       Date:  2015-08-05       Impact factor: 4.147

3.  Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancer.

Authors:  K Lien; V C Tam; Y J Ko; N Mittmann; M C Cheung; K K W Chan
Journal:  Curr Oncol       Date:  2015-12       Impact factor: 3.677

4.  Cost-Effectiveness of a Comprehensive Approach for Hypertension Control in Low-Income Settings in Argentina: Trial-Based Analysis of the Hypertension Control Program in Argentina.

Authors:  Federico Augustovski; Martín Chaparro; Alfredo Palacios; Lizheng Shi; Andrea Beratarrechea; Vilma Irazola; Adolfo Rubinstein; Katherine Mills; Jiang He; Andrés Pichon Riviere
Journal:  Value Health       Date:  2018-08-30       Impact factor: 5.725

5.  The valuation of the EQ-5D in Portugal.

Authors:  Lara N Ferreira; Pedro L Ferreira; Luis N Pereira; Mark Oppe
Journal:  Qual Life Res       Date:  2013-06-08       Impact factor: 4.147

6.  Quality of life of patients with rheumatoid arthritis in Argentina: reliability, validity, and sensitivity to change of a Spanish version of the Rheumatoid Arthritis Quality of Life questionnaire.

Authors:  Christian A Waimann; Fernando M Dal Pra; Maria F Marengo; Emilce E Schneeberger; Susana Gagliardi; Jose A Maldonado Cocco; Mónica Sanchez; A Garone; Rafael E Chaparro del Moral; Oscar L Rillo; Mariana Salcedo; Javier E Rosa; F Ceballos; Enrique R Soriano; Gustavo Citera
Journal:  Clin Rheumatol       Date:  2012-04-04       Impact factor: 2.980

Review 7.  Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?

Authors:  Eleanor M Pullenayegum; Kuhan Perampaladas; Kathryn Gaebel; Brett Doble; Feng Xie
Journal:  Eur J Health Econ       Date:  2014-09-25

8.  Cost-effectiveness of a hypertension management programme in an elderly population: a Markov model.

Authors:  Gastón Perman; Emiliano Rossi; Gabriel D Waisman; Cristina Agüero; Claudio D González; Carlos L Pallordet; Silvana Figar; Fernán González Bernaldo de Quirós; Joann Canning; Enrique R Soriano
Journal:  Cost Eff Resour Alloc       Date:  2011-04-05

9.  Valuing EQ-5D health states for Sri Lanka.

Authors:  Sanjeewa Kularatna; Jennifer A Whitty; Newell W Johnson; Ruwan Jayasinghe; Paul A Scuffham
Journal:  Qual Life Res       Date:  2014-12-28       Impact factor: 4.147

10.  Assessment of children's own health status using visual analogue scale and descriptive system of the EQ-5D-Y: linkage between two systems.

Authors:  X Y Wu; A Ohinmaa; J A Johnson; P J Veugelers
Journal:  Qual Life Res       Date:  2013-07-27       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.